Skip to main content
. 2021 Jul 8;43(4):577–590. doi: 10.1007/s00281-021-00869-6

Table 3.

Compounds used alone or in combination with other drugs for clinical trials in patients with metabolic associated steatohepatitis. Steroidal (light purple) and non-steroidal (intermediate purple) agonists of bile acid receptors as well as FGF19 analogs (dark purple)

graphic file with name 281_2021_869_Tab3_HTML.jpg